Answers are grounded in this paper and cite their sources.
Cross-sectional analysis identifies cognitive impairment prevalence in HIV patients, highlighting ART and comorbidities importance.
Background: Neurocognitive impairment remains a significant complication in people living with HIV (PLWH) despite widespread antiretroviral therapy (ART). Mild-to-moderate forms persist and are often underdiagnosed, yet regional data from Western India remain limited. Aims: To determine the prevalence of Montreal Cognitive Assessment (MoCA)-defined cognitive impairment and identify associated correlates at a tertiary ART centre in South Gujarat, India. Materials and Methods: We conducted a cross-sectional study of 231 HIV-positive adults over 6 months. Participants were assessed using MoCA (threshold <26), and those with impaired cognition were further characterised using the Frascati criteria as a descriptive severity framework. Sociodemographic variables, ART history, CD4 counts and comorbidities were evaluated using SPSS version 25 ( P < 0.05 significant). Results: The prevalence of MoCA-defined cognitive impairment was 22.07% ( n = 51), representing a likely ceiling estimate given the uniform cutoff applied without education-based adjustment. Most patients presented with an asymptomatic-range profile (18.61%); 3.46% had a mild impairment profile, and none demonstrated severity consistent with HIV-associated dementia. Significant correlates included lower CD4 count ( P < 0.001), shorter ART duration ( P = 0.0004), tuberculosis history ( P = 0.0351), opportunistic infections ( P < 0.001), lower haemoglobin ( P < 0.001) and prior hospitalisation ( P = 0.0001). Lower educational attainment and low socioeconomic status showed non-significant trends. Conclusions: Cognitive impairment affects a substantial proportion of ART-treated individuals. Findings support early ART initiation and cognitive screening; however, causality cannot be inferred from this cross-sectional design. Future studies should incorporate depression screening and viral load data.
No takes yet. Share an insight, caveat, or question.
Dandge et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: